Backed by two leading medical journals, researchers propose a new plan to publish clinical trial data that pharmaceutical companies often try to bury.
Backed by two leading medical journals, researchers propose a new plan to publish clinical trial data that pharmaceutical companies often try to bury.
A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.
The European Commission approves the Western hemisphere’s first gene therapy, aimed at correcting a lipid-processing disorder.
The FDA approves drugs faster and earlier than regulatory agencies in other countries.
The European Medicines Agency revised its policy on conflicts of interest in response to concerns regarding its ability to conduct independent evaluations.
Page 1 of 1